Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

SiriusPoint (SPNT-PB) Cash & Equivalents (2016 - 2025)

SiriusPoint (SPNT-PB) has disclosed Cash & Equivalents for 14 consecutive years, with $731.2 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 7.21% to $731.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $731.2 million through Dec 2025, up 7.21% year-over-year, with the annual reading at $731.2 million for FY2025, 7.21% up from the prior year.
  • Cash & Equivalents hit $731.2 million in Q4 2025 for SiriusPoint, up from $582.4 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.0 billion in Q2 2021 to a low of $582.4 million in Q3 2025.
  • Historically, Cash & Equivalents has averaged $763.9 million across 5 years, with a median of $731.8 million in 2025.
  • Biggest five-year swings in Cash & Equivalents: surged 109.16% in 2021 and later fell 29.63% in 2024.
  • Year by year, Cash & Equivalents stood at $999.8 million in 2021, then decreased by 29.46% to $705.3 million in 2022, then skyrocketed by 37.42% to $969.2 million in 2023, then dropped by 29.63% to $682.0 million in 2024, then rose by 7.21% to $731.2 million in 2025.
  • Business Quant data shows Cash & Equivalents for SPNT-PB at $731.2 million in Q4 2025, $582.4 million in Q3 2025, and $732.4 million in Q2 2025.